Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

 

david_beeson.jpg

DAVID BEESON, Nuffield Department of Clinical Neurosciences


David Beeson graduated from Magdalene College, Cambridge, and gained his PhD at Imperial College, London. He moved to the then Institute of Molecular Medicine, at the University of Oxford, to work on disorders of neuromuscular transmission in 1988, with a particular focus on inherited myasthenic syndromes. He was made Professor of Neuroscience in 2004 and was elected Fellow of the Academy of Medical Sciences in 2018.                                                        

Research group link

David Bennettt

DAVID BENNETT, Nuffield Department of Clinical Neurosciences

David is Professor of neurology and neurobiology, a senior Wellcome clinical scientist in the Nuffield Department of Clinical Neuroscience at the University of Oxford and honorary consultant neurologist. His sub-specialty interest is peripheral neuropathy and neuropathic pain; he administers the neuropathy and pain channelopathy clinic at Oxford University Hospitals. His research interest is nerve injury/repair and neuropathic pain. He leads DOLORisk, an EU-based consortium investigating risk factors and determinants of neuropathic pain.

Research group link

StefenBradysq.JPG

STEFEN BRADY, OUH-FT Neurology Service

Stefen Brady studied medicine at Trinity College Medical School in Dublin. He trained in muscle diseases with Dr David Hilton-Jones at the John Radcliffe Hospital in Oxford and with Prof. Mike Hanna at MRC Centre for Neuromuscular Diseases in London. He was awarded a DPhil by the University of Oxford for his thesis, A Clinicopathological Study of Inclusion Body Myositis (IBM), in 2014. Dr Brady has worked as a Specialist Neuromuscular Consultant since 2016.

Kay Davies

KAY DAVIES, Department of Physiology, Anatomy and Genetics

Kay is Dr Lee’s Professor of Anatomy at the University of Oxford and directs the MRC Functional Genomics Unit. Kay’s work has paved the way for the use of mini dystrophin AAV gene delivery, contributed to exon-skipping therapy approaches and identified the dystrophin-related protein, utrophin targeted to prevent pathology. She co-founded Summit Therapeutics (antibiotics bio-tech), is a founding fellow of the UK Academy of Medical Sciences and is a Fellow of the Royal Society. Kay is Dame Commander of the British Empire for services to science.

Research group link

Yin Yao Dong

YIN YAO DONG, Nuffield Department of Clinical Neurosciences

Dr Yin Yao Dong is a MRC Career Development Fellow at the Nuffield Department of Clinical Neuroscience. His research is focused on understanding why abnormalities in the ubiquitous process of protein N-glycosylation, can lead to congenital myasthenic syndromes, and the specific dysfunction of the neuromuscular junction. To do so, he leads a multidisciplined collaboration using methods in biochemistry, structural biology, molecular biology and glycomics.

Research group link

Victoria Nesbitt

VICTORIA NESBITT, NHS Highly Specialised Services for Rare Mitochondrial Disorders

Victoria is a Consultant Paediatrician in Mitochondrial Diseases and Honorary Senior Clinical Lecturer in Paediatrics.  She is the Clinical Lead for the NHS Highly Specialised Service for Rare Mitochondrial Disorders in Oxford. She strives to increase awareness of mitochondrial disease in order to diagnose children earlier. Victoria is the Principal Investigator for Oxford on the MRC Mitochondrial Diseases Patient Cohort Study (UK). Her research interests also include the natural history of mitochondrial disorders and phenotype-genotype correlations.

Research group link

Jacqueline Palace

JAQUELINE PALACE, Nuffield Department of Clinical Neurosciences

Jackie Palace is a consultant neurologist in Oxford and Associate Professor of Nuffield Department of Clinical Neurosciences, University of Oxford.  She runs a national service for congenital myasthenic syndromes, a myasthenia service for adults and children, leads the Oxford Multiple Sclerosis group and jointly a UK neuromyelitis optica service.  Her research interests are the genetics and immunological basis of myasthenias, treatment trials, immunology, pathology, biomarkers, genetics and imaging.  She is the Oxford lead for the European Rare Network for Neuromuscular Diseases.

Research group link

JoannaPoulton.jpg

JOANNA POULTON, Women's and Reproductive Health

Joanna Poulton is Professor and Honorary Consultant in Mitochondrial Genetics at Oxford and at Great Ormond St Hospital. In mitochondrial DNA (mtDNA) diseases, patients may harbour a mixture of normal and damaged mtDNA (heteroplasmy), the mixture determining the disease severity.  Jo’s data on the transmission of mtDNA (“the bottleneck”) were a breakthrough for the feasibility of mtDNA prenatal diagnosis and ultimately for the high-profile mitochondrial replacement therapy, “three parent babies”.  Current work focusses on exploiting mitophagy to treat mitochondrial disease.

Research group link

SitharaRamdas.png

SITHARA RAMDAS, OUH Neurology

Sithara Ramdas is a Consultant Paediatric Neurologist at the Oxford Children’s Hospital and Honorary Senior Clinical Lecturer with the University of Oxford. Her areas of specialist interest are neuromuscular disorders and neuroimmunology. She runs a multi-disciplinary regional paediatric neuromuscular service. She is the research lead for the paediatric neurology department. She is also works within the National Highly Specialised Services for Congenital Myasthenia Syndromes and for Neuromyelitis Optica.

CarloRinaldisq.png

CARLO RINALDI, Department of Paediatrics

Carlo Rinaldi, MD PhD is Associate Professor at the University of Oxford and Honorary Consultant Neurologist at the John Radcliffe Hospital in Oxford and at the National Hospital for Neurology and Neurosurgery in London. His research interests span from gene identification to treatment development in neuromuscular conditions. Carlo is currently working on gene therapy strategies to counteract muscle atrophy in genetic conditions such as spinal and bulbar muscular atrophy and Duchenne muscular dystrophy.

Research group link

SRinaldi.jpg SIMON RINALDI, Nuffield Department of Clinical Neurosciences

Dr Simon Rinaldi, MRCP(Neuro), PhD, is Associate Professor at the University of Oxford, MRC Clinician Scientist and Honorary Consultant Neurologist. Dr Rinaldi leads Oxford's programme of research into the inflammatory neuropathies, disabling disorders characterised by progressive paralysis and loss of sensation. However, the immuno-pathological mechanisms driving them are incompletely characterised, and therapies for these conditions have not advanced in over 20 years. His group have developed cell-based assays to improve diagnosis and treatment selection and use human stem-cell based myelinating co-cultures to study disease mechanisms.

Research group link

ARussellsq.png

ANGELA RUSSEL, Chemistry

Angela Russell is Professor of Medicinal Chemistry, Departments of Chemistry and Pharmacology at the University of Oxford.  She has realised several successful multidisciplinary research collaborations, including identifying small molecules to upregulate utrophin for the treatment of Duchenne Muscular Dystrophy and the discovery and development of small molecules to manipulate stem cell fate. In 2013 she co-founded the Oxford spin-out MuOx Ltd, acquired by Summit Therapeutics plc, and co-founded OxStem Ltd in May 2016.

Research group link

LaurentServais

LAURENT SERVAIS, Department of Paediatrics

Laurent Servais is Professor of Child Neurology at the University of Liège, and future (Sep 2019) Professor of Paediatric Neuromuscular Disease at the University of Oxford. He is Head of the Neuromuscular Reference Centre in Liège and is one of the creators and director of Institute I-Motion in Paris. He specialises in clinical programs in DMD and SMA and leads the newborn screening program for SMA in southern Belgium and a program that aims to bring digital endpoints to regulatory qualification.

Research group link

KevinTalbotsq.png

KEVIN TALBOT, Nuffield Department of Clinical Neurosciences

Kevin is Professor of Motor Neuron Biology and Head of the Division of Clinical Neurology at the University of Oxford. His research focuses on in vitro and in vivo modelling of pathogenesis in ALS, FTD and SMA to elucidate the mechanisms of motor neuron degeneration and accelerate the identification of disease modifying treatments. He also leads a specialist clinical service that provides a multidisciplinary team-based care for patients with ALS and SMA.

Research group link

MartinTurner.jpg

MARTIN TURNER, Nuffield Department of Clinical Neurosciences

Martin Turner is Professor of Clinical Neurology & Neuroscience within Oxford University’s Nuffield Department of Clinical Neurosciences, consultant neurologist to the John Radcliffe Hospital, and co-director of the Oxford MND Clinic. Working with MND (ALS) patients for 20 years, his focus is the development of biomarkers from neuroimaging and biofluid assays, to accelerate therapy discovery. He currently chairs the Research Committee of the Association of British Neurologists, with oversight of their flagship Research Training Fellowship scheme.

Research group link

MatthewWood

MATTHEW WOOD, Department of Paediatrics

Matthew is Professor of Neuroscience and Deputy Head of the Medical Sciences Division at the University of Oxford. He directs the Laboratory of RNA biology and Neuromuscular Disease investigating development of RNA-based medicines for neuromuscular disease including advanced generation antisense oligonucleotides. He is Director of the Oxford Rare Disease Centre, founder of the biotech spin-outs Evox Therapeutics (therapeutic exosome technology) and PepGen (peptide based drug delivery technology).

Research group link